Ethiopia: Ethiopia to Immunize Over 1.8 Million Girls Against Human Papillomavirus
[WHO-AFRO] Addis Ababa -- A human papillomavirus (HPV) vaccination campaign that aims to immunize over 1.8 million 14-year-old girls in nine regions against HPV is underway. The campaign commenced on 10 January 2022 and will end on 22 January. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 23, 2022 Category: African Health Source Type: news

Nigeria: Niger State Govt Begins Cervical Cancer Services in Line With WHO's Recommendation
[WHO-AFRO] In line with the World Health Organization's (WHO) recommendation for screening and treatment to prevent cervical cancer, the Niger State Government has begun screening women for Human Papillomavirus (HPV) and cancer prevention services in nine Local Government Areas (LGA). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 21, 2022 Category: African Health Source Type: news

Covax, the Developing World ’ s Hope against COVID, Has Made It Only Halfway
Delivery of syringes for the vaccination campaign in El Salvador. Latin American countries have made steady progress in immunizing their populations, partly through direct negotiations between their governments and suppliers and partly through international cooperation. CREDIT: PAHO By Humberto MárquezCARACAS, Jan 20 2022 (IPS) The Covax initiative, the hope of the countries of the developing South to immunize their populations against COVID-19, only met half of its goals in 2021. And as 2022 begins, and the omicron variant of the virus is spreading fast, the scheme still depends on the decisions of pharmaceutical c...
Source: IPS Inter Press Service - Health - January 20, 2022 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: COVID-19 Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Humanitarian Emergencies Regional Categories TerraViva United Nations COVAX COVID-19 vaccines Source Type: news

UofL researchers reveal how oral bacteria suppress protection against viral growth
 Bacteria that cause periodontal disease reduce oral defense and increase viral growth By Betty Coffman LOUISVILLE, Ky. – Researchers from the University of Louisville School of Dentistry and their colleagues have discovered details of how proteins produced by oral epithelial cells protect humans against viruses entering the body through the mouth. They also found that oral bacteria can suppress the activity of the se cells, increasing vulnerability to infection. A family of proteins known as interferon lambdas produced by epithelial cells in the mouth serve to protect humans from viral infection,...
Source: Dental Technology Blog - January 6, 2022 Category: Dentistry Source Type: news

Throat Cancers Tied to HPV Are Rising Among U.S. Men, Women
TUESDAY, Dec. 21, 2021 -- You might have heard a lot about the human papillomavirus (HPV) and its role in cervical cancer, but this sexually transmitted virus can also cause another type of cancer. Rates of oropharyngeal cancer, which occurs in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 21, 2021 Category: General Medicine Source Type: news

Tanzania: Health Teams Tasked in Hpv Awareness Creation
[Daily News] COMMUNITY Health Management Teams (CHMT) in district councils have been advised to step up efforts in raising awareness among members of the public on the benefits of Human Papillomavirus Vaccines (HPV1&HPV2) in protecting girls under 15 against cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 14, 2021 Category: African Health Source Type: news

Why More Kids Aren ’t Getting the HPV Vaccine
The human papillomavirus vaccine can prevent six potentially lethal malignancies, but inoculation is meeting with rising resistance from parents. (Source: NYT Health)
Source: NYT Health - December 13, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Cervical Cancer Vaccination and Immunization Head and Neck Cancer Sexually Transmitted Diseases Parenting Teenagers and Adolescence Youth Cervarix (Vaccine) JAMA Pediatrics (Journal) Source Type: news

Cancer breakthrough: New blood test may detect cancer earlier and more accurately
THE HUMAN papillomavirus is a group of STDs that can produce cancer in several areas of the body. The most common type of cancer is in the head and neck, and a new blood test may make catching it easier. Symptoms of head and neck cancer can include a sore threat, change in voice and pain in the ears. (Source: Daily Express - Health)
Source: Daily Express - Health - December 8, 2021 Category: Consumer Health News Source Type: news

Tanzania: Send Your Daughters for Hpv Vaccination, Parents Urged
[Daily News] THE MINISTRY of Health, Community Development, Gender, Elderly and Children has urged parents to ensure that their daughters take the Human Papillomavirus Vaccine (HPV) to protect them from cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2021 Category: African Health Source Type: news

HPV Vaccine Has Protected Thousands Of People From Cervical Cancer, According To New Study
The HPV (human papillomavirus) vaccine pledged to help protect students between the ages of 12 and 13 from cervical cancer, among other cancers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 1, 2021 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Single-Dose HPV Vaccination Highly Effective Single-Dose HPV Vaccination Highly Effective
Only 15% of girls globally are vaccinated against human papillomavirus (HPV), but single-dose vaccination could pave the way for much better infection control, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Newspath June 2014 - Role of p16 and Ki67 Immunohistochemistry in the Evaluation of Cervical Dysplasia
Cervical dysplasia refers to abnormal microscopic changes in the cells on the surface of the cervix. It is usually associated with human papillomavirus infection and is frequently detected on Pap smears as "squamous intraepithelial lesions." (Source: NewsPath - Pathology News for the Medical Community)
Source: NewsPath - Pathology News for the Medical Community - November 11, 2021 Category: Pathology Source Type: news

HPV Vaccination:'Dramatic' Reduction in Cervical Cancer HPV Vaccination:'Dramatic' Reduction in Cervical Cancer
New data from England show the success of the national human papillomavirus (HPV) vaccination program in preventing cervical cancer and noninvasive precursor lesions in young women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Older HPV vaccine cuts cervical cancer rate up to 87%, study finds
Young women who were vaccinated against human papillomavirus in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked... #glaxosmithkline #thelancet (Source: Reuters: Health)
Source: Reuters: Health - November 3, 2021 Category: Consumer Health News Source Type: news

HPV vaccination lowers cervical cancer risk up to 87%, British study finds
Becoming vaccinated against the human papillomavirus reduces a woman's risk for cervical cancer up to 87%, a study published Wednesday by the Lancet found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 3, 2021 Category: Consumer Health News Source Type: news

Inovio, AstraZeneca terminate cancer vaccine partnership
MedImmune Ltd., the global biologics research and development arm of AstraZeneca (NYSE: AZN), is terminating a cancer therapy partnership it has with Inovio Pharmaceuticals. The partnership, formed in 2015, gave MedImmune of Gaithersburg, Maryland, exclusive rights to Inovio's experimental DNA-based cancer vaccine, known as INO-3112, for cancers caused by human papillomavirus (HPV) types 16 and 18. MedImmune renamed the new drug candidate as MED10457 after acquirin g its exclusive rights. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 2, 2021 Category: Pharmaceuticals Authors: John George Source Type: news

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Health - November 1, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Science - November 1, 2021 Category: Science Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Africa: UN Honours Henrietta Lacks, Whose Cells Transformed Medical Research Worldwide
[UN News] For the past seven decades, the cells of Henrietta Lacks, a Black American woman who died of cervical cancer, have saved countless lives, and made numerous scientific breakthroughs possible, such as the human papillomavirus and polio vaccines, drugs for HIV treatment, together with cancer and COVID-19 research. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2021 Category: African Health Source Type: news

How Long Before Genital Warts Go Away
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 23, 2021 Category: General Medicine Source Type: news

HPV Infection During Pregnancy Ups Risk for Premature Birth HPV Infection During Pregnancy Ups Risk for Premature Birth
Persistent human papillomavirus (HPV) 16 and HPV 18 infections during a pregnancy may be associated with an increased risk of premature birth.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 20, 2021 Category: Infectious Diseases Tags: Ob/Gyn & Women ' s Health News Source Type: news

Sexually transmitted infections fall during pandemic
Genital warts and herpes saw the biggest decrease, the figures for England reveal. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 7, 2021 Category: Consumer Health News Source Type: news

Adults need to take seriously vaccines for other diseases besides covid-19 and flu
Thousands of them get sick annually from illnesses — such as pertussis, shingles, human papillomavirus and pneumonia — that could have been prevented by vaccination. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 6, 2021 Category: Consumer Health News Authors: Marlene Cimons Source Type: news

Teen Vaccine Coverage Mainly Remained Stable in 2020
FRIDAY, Sept. 3, 2021 -- In 2020, adolescent coverage with recommended vaccines remained stable, with increased coverage for human papillomavirus (HPV) vaccine, according to research published in the Sept. 3 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2021 Category: Pharmaceuticals Source Type: news

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020
This report describes adolescent vaccination coverage in 2020. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 2, 2021 Category: American Health Tags: Adolescent Health HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Tetanus Vaccination Vaccines Source Type: news

Human Papillomavirus-Associated Head and Neck Cancer Human Papillomavirus-Associated Head and Neck Cancer
Review the epidemiology, screening, presentation, diagnosis, prognosis, and prevention of HPV-positive oropharyngeal squamous cell carcinoma, with a focus on the primary care provider's role.Journal of the American Board of Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 2, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

NIDCR's Fall 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Fall 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   NIDCR News 5 Q&As About “Oral Health in America: Advances and Challenges” NIDCR issued a brief Q&A regarding details of the forthcoming report Oral Health in America: Advances and Challenges, which will be published in Fall 2021. This comprehensive report will examine improvements in oral health over t...
Source: NIDCR Science News - September 1, 2021 Category: Dentistry Source Type: news

How can I shift stubborn verrucas? DR MARTIN SCURR answers your health questions
DR MARTIN SCURR: Warts (which are termed verrucas when on the feet) are caused by the skin being infected with one or more members of the human papillomavirus (HPV) family. (Source: the Mail online | Health)
Source: the Mail online | Health - August 24, 2021 Category: Consumer Health News Source Type: news

Prevalence of High-Risk HPV Types Dwindled Since Vaccine Approval Prevalence of High-Risk HPV Types Dwindled Since Vaccine Approval
The human papillomavirus (HPV) vaccine has substantially reduced the prevalence of the most common high-risk HPV types, even though, in a surprise, overall HPV prevalence increased over time.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2021 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

LEEP Seems More Likely Than Cryotherapy to Clear HPV Infection in Women With HIV LEEP Seems More Likely Than Cryotherapy to Clear HPV Infection in Women With HIV
In women with HIV, a loop electrosurgical excision procedure (LEEP) was 40% more likely than cryotherapy to clear high-risk human papillomavirus (hrHPV) in a secondary analysis of a randomized trial in Africa.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 17, 2021 Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news

Cutaneous Beta-HPV May Up Risk for Cutaneous Squamous Cell Carcinoma
WEDNESDAY, Aug. 11, 2021 -- Cutaneous beta-human papillomavirus (HPV) may predict development of cutaneous squamous cell carcinoma (cuSCC), according to a study published online July 15 in Cancer Research. Dana E. Rollison, Ph.D., from the Moffitt... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 11, 2021 Category: Pharmaceuticals Source Type: news

American Society for Colposcopy and Cervical Pathology discusses updated American Cancer Society guidelines on cervical cancer screening
(Wolters Kluwer Health) Last year, the American Cancer Society (ACS) issued an updated set of guidelines for cervical cancer screening - emphasizing the shift toward screening with primary human papillomavirus (HPV) testing. While the ACS recommendation accounts for a transition period to implement primary HPV screening, additional factors should be considered to operationalize these guidelines, according to a special white paper in the July issue of the Journal of Lower Genital Tract Disease (JLGTD), official journal of ASCCP. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2021 Category: Cancer & Oncology Source Type: news

HPV Vaccine in Management of HPV-associated Cutaneous Lesions HPV Vaccine in Management of HPV-associated Cutaneous Lesions
Is there a role for the HPV vaccine in treating HPV-related dermatologic conditions such as common warts, genital warts, keratinocyte carcinoma, and epidermodysplasia verruciformis?Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 18, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

What is HPV in women? How do you know if you’ve had HPV?
HUMAN papillomavirus, better known as HPV, is the name for a group of viruses that can cause genital warts or cancer. What does HPV look like in women and how do you know if you've had it? (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2021 Category: Consumer Health News Source Type: news

HPV vaccine has a significant impact even if all girls and boys are not vaccinated
(Tampere University) Human papillomavirus (HPV) vaccines applied in national vaccination programs protect against most cancers associated with oncogenic, high-risk (hr) HPV types. Two recent studies demonstrate the impact of gender-neutral HPV vaccination in the overall protection against hrHPV infections already with low vaccination coverage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2021 Category: Cancer & Oncology Source Type: news

ASCO: Incidence of Cervical Cancer Has Decreased in the United States
TUESDAY, June 1, 2021 -- The incidence of cervical cancer has decreased, while the incidence of other human papillomavirus (HPV)-related cancers has increased in the United States, according to a study scheduled to be presented at the annual meeting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2021 Category: Pharmaceuticals Source Type: news

Infection with human papillomavirus linked to higher risk of preterm birth
(University of Gothenburg) Women carrying human papillomavirus (HPV) run an elevated risk of preterm birth, a University of Gothenburg study shows. A connection can thus be seen between the virus itself and the risk for preterm birth that previously has been observed in pregnant women who have undergone treatment for abnormal cell changes due to HPV. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 31, 2021 Category: Infectious Diseases Source Type: news

Quickstats: Percentage of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine, by Race and Hispanic Origin and Sex - National Health Interview Survey, United States, 2019
This report describes the percentage of adults aged 18-26 years who received a human papillomavirus vaccine, by race and Hispanic origin and sex. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 27, 2021 Category: American Health Tags: Adult Vaccinations HPV Infection (Human Papillomavirus) HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news

To Beat Covid, Beat HIV, & Beat Inequality, Find the Money
A woman is vaccinated against COVID-19 in the indigenous community of Concordia, Colombia. Meanwhile, UN Secretary-General Antonio Guterres repeated his call for the G20 to establish a Task Force “able to deal with the pharmaceutical companies and other key stakeholders”, which would address equitable vaccine distribution through the COVAX global initiative. Credit: WHO/Nadege MazarsBy Winnie ByanyimaGENEVA, May 27 2021 (IPS) In this time of intersecting crises – the Covid crisis, the HIV crisis, the inequality crisis, and more – progress on all these crises is being blocked by another crisis: finan...
Source: IPS Inter Press Service - Health - May 27, 2021 Category: International Medicine & Public Health Authors: Winnie Byanyima Tags: Aid Development & Aid Featured Global Headlines Health Human Rights Humanitarian Emergencies Population Poverty & SDGs TerraViva United Nations Source Type: news

UVA Cancer Center, other top US cancer centers urge cancer-preventing HPV vaccinations
(University of Virginia Health System) UVA Cancer Center is joining 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations in urging physicians, parents and young adults to get cancer-preventing human papillomavirus (HPV) vaccinations back on track. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2021 Category: International Medicine & Public Health Source Type: news

HPV vaccine shows success in gay, bisexual men
(Monash University) A study by Monash University and Alfred Health found a 70 per cent reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of the school-based HPV vaccination program. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 25, 2021 Category: International Medicine & Public Health Source Type: news

Sanford Burnham Prebys and other top US cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
(Sanford Burnham Prebys Medical Discovery Institute) Sanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 20, 2021 Category: Cancer & Oncology Source Type: news

HPV Vaccination Is Lowering U.S. Cervical Cancer Rates
WEDNESDAY, May 19, 2021 -- In a finding that offers the first evidence that the human papillomavirus (HPV) vaccine is indeed protecting women from cervical cancer, new research shows cases in the United States have slowly but steadily declined over... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 19, 2021 Category: General Medicine Source Type: news

Gold leaf could help diagnose viral infections in low-resource settings
(American Chemical Society) Gold leaf -- gold metal hammered into thin sheets -- is used by artists and crafters to gild picture frames, artwork and clothing. Despite its luxurious appearance, the material is affordable and available at most craft stores. Now, researchers reporting inACS Central Science have developed gold leaf electrodes that, in combination with a CRISPR-based assay, could sensitively detect human papillomavirus (HPV) DNA in human samples. The method also could be modified to diagnose other viral infections. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 12, 2021 Category: International Medicine & Public Health Source Type: news

HPV Vaccination Rates Low for Young Adults
THURSDAY, May 6, 2021 -- Self-reported human papillomavirus (HPV) vaccination rates for young adults, whether for receipt of a dose at any age or between ages 18 and 21 years, are low, although they increased from 2010 to 2018, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 6, 2021 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years
TUESDAY, May 4, 2021 -- Despite increases since 2008, human papillomavirus (HPV) vaccination rates are suboptimal within ages 9 to 12 years, according to a study published online May 3 in Pediatrics. Onyema Greg Chido-Amajuoyi, M.B.B.S., M.P.H.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Too Few Young Men Have Gotten the HPV Vaccine
FRIDAY, April 30, 2021 -- The HPV vaccine isn't reaching enough young American men, researchers report. The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus (HPV), the most common sexually transmitted... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 30, 2021 Category: General Medicine Source Type: news

HPV vaccination in young adults
(JAMA Network)What The Study Did:Survey data were used to estimate the rate of human papillomavirus (HPV) vaccination among young adults ages 18 to 21 in the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2021 Category: Infectious Diseases Source Type: news

Mayo Clinic Q & amp;A podcast: Head and neck cancers are becoming increasingly common
There are many causes of head and neck cancers, and treatment is complicated. And one of the fastest growing demographic of cancers in the U.S. is human papillomavirus (HPV) in younger people, says Dr. Daniel Ma, a Mayo Clinic radiation oncologist. "This is a treatable disease," says Dr. Ma. "It's a disease that's very responsive [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 19, 2021 Category: Databases & Libraries Source Type: news

First patient-derived organoid model for cervical cancer
(Hubrecht Institute) Researchers from the group of Hans Clevers developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. The researchers used the platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study human papillomavirus (HPV), which is one of the main causes of cervical cancer. The results will be published in Cell Stem Cell on the 13th of April, 2021. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2021 Category: Cancer & Oncology Source Type: news